Nifty 17857.25 (-1.94%)
Sensex 59984.7 (-1.89%)
Nifty Bank 39508.95 (-3.34%)
Nifty IT 34913.6 (-1.66%)
Nifty Financial Services 18987.55 (-2.65%)
Adani Ports 688.10 (-7.74%)
Asian Paints 3116.30 (0.70%)
Axis Bank 758.35 (-3.70%)
B P C L 420.80 (-1.61%)
Bajaj Auto 3700.70 (-2.01%)
Bajaj Finance 7484.25 (0.03%)
Bajaj Finserv 17987.70 (-0.13%)
Bharti Airtel 689.75 (-1.79%)
Britannia Inds. 3681.90 (-0.43%)
Cipla 891.75 (-3.33%)
Coal India 166.55 (-4.06%)
Divis Lab. 5121.15 (-0.55%)
Dr Reddys Labs 4569.95 (-1.99%)
Eicher Motors 2527.50 (-2.18%)
Grasim Inds 1702.40 (-1.50%)
H D F C 2900.80 (-0.49%)
HCL Technologies 1152.00 (-2.14%)
HDFC Bank 1593.60 (-2.99%)
HDFC Life Insur. 683.10 (-1.55%)
Hero Motocorp 2667.75 (-0.83%)
Hind. Unilever 2389.65 (-0.29%)
Hindalco Inds. 468.80 (-2.30%)
I O C L 128.65 (-1.64%)
ICICI Bank 798.70 (-4.35%)
IndusInd Bank 1176.00 (2.93%)
Infosys 1703.90 (-1.45%)
ITC 225.10 (-5.60%)
JSW Steel 667.45 (-2.55%)
Kotak Mah. Bank 2098.50 (-4.10%)
Larsen & Toubro 1814.25 (1.66%)
M & M 883.85 (-0.33%)
Maruti Suzuki 7369.70 (0.18%)
Nestle India 18991.40 (-0.07%)
NTPC 137.35 (-2.80%)
O N G C 150.20 (-4.88%)
Power Grid Corpn 185.90 (-2.29%)
Reliance Industr 2598.60 (-1.10%)
SBI Life Insuran 1167.10 (-1.59%)
Shree Cement 28193.05 (0.30%)
St Bk of India 501.35 (-3.43%)
Sun Pharma.Inds. 807.60 (-2.12%)
Tata Consumer 809.70 (-1.11%)
Tata Motors 481.05 (-3.38%)
Tata Steel 1299.60 (-2.00%)
TCS 3421.65 (-1.95%)
Tech Mahindra 1533.30 (-2.20%)
Titan Company 2375.15 (-3.45%)
UltraTech Cem. 7446.65 (1.26%)
UPL 729.90 (-1.56%)
Wipro 656.90 (-2.12%)

Chemplast Sanmar IPO Listing

Chemplast Sanmar

On 24th August, Chemplast Sanmar listed at a marginal premium of 1.66% on NSE, but later slipped into a discount. The stock could not hold on to the premium listing as selling pressure piled up through the day. 

The overall subscription of 2.17X in the Chemplast Sanmar IPO was tepid, especially when you consider that HNI portion was subscribed just 1.03X and QIB portion 2.70X, despite a successful anchor placement ahead of the IPO. Here is the Chemplast Sanmar listing story on 24th August.

Check: Chemplast Sanmar IPO Subscription

The IPO price was fixed at the upper end of the band at Rs.541 despite a very tepid 2.17X subscription. On 24th Aug, the stock of Chemplast Sanmar listed on the NSE at a price of Rs.550, a premium of 1.66% over the issue price. On the BSE, the stock listed at a price of Rs.525, representing listing discount of -2.96%.

On the NSE, Chemplast Sanmar closed at Rs.536, a first day closing discount of -0.92% on the issue price of Rs.541. On the BSE, the stock closed at Rs.534.90, a first day closing discount of -1.13% on the issue price. Despite the bounce from lower levels on BSE, the stock closed below the IPO price.

On Day-1 of listing, Chemplast Sanmar touched a high of Rs.550 on the NSE and a low of Rs.510. The stock traded a total of 142.54 lakh shares on NSE amounting to value of Rs.769.12 crore. In terms of traded value, Chemplast Sanmar was the sixteenth most traded stock on NSE.

On the BSE, Chemplast Sanmar touched a high of Rs.550 and a low of Rs.510.30. On BSE, the stock traded a total of 20.42 lakh shares amounting to value of Rs.110.02 crore. At the close of Day-1, Chemplast Sanmar had a market capitalization of Rs.8,457 crore with free-float market cap of just Rs.2,114 crore.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
There is some issue, try later
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Aptus Value Housing IPO Listing


On 24th August, Aptus Value Housing listed at a discount of -5.67%, but the stock managed to recoup losses by close. Both the NSE and BSE are showing positive returns on Aptus Value Housing but that is misleading because the exchanges consider returns from the opening price. Compared to the IPO price, the stock closed lower. 

The overall subscription of 17.20X in the August, Aptus Value Housing IPO was largely supported by HNI subscription at 33.91X and QIB subscription at 32.41X, even as retail participation was just 1.35X. Here is the Aptus Value Housing listing story on 24th August.

The IPO price was fixed at the upper end of the band at Rs.353 after a decent response at 17.20X subscription. On 24th Aug, the stock of Aptus Value Housing listed on the NSE at a price of Rs.333, a discount of -5.67% on the issue price. On the BSE, the stock is listed at a price of Rs.329.95, representing a listing discount of -6.53%.

On the NSE, Aptus Value Housing bounced back to close at Rs.352, just Rs.1 below the issue price. On the BSE, the stock closed at Rs.346.50, a first-day closing discount of -1.84% on the issue price. Interestingly, BSE has displayed returns on opening price and issue price.

On Day-1 of listing, Aptus Value Housing touched a high of Rs.354.80 on the NSE and a low of Rs.333. The stock traded a total of 325.81 lakh shares on NSE amounting to the value of Rs.1,120.31 crore.  In terms of traded value, Aptus Value Housing was the seventh most traded stock on NSE.

On the BSE, Aptus Value Housing touched a high of Rs.354.60 and a low of Rs.329.95. On BSE, the stock traded a total of 16.21 lakh shares amounting to the value of Rs.55.98 crore. At the close of Day-1, Aptus Value Housing had a market capitalization of Rs.17,172 crore with a free-float market cap of just Rs.1,889 crore.

Next Article

NSE Revises Stock Selection Criteria for Nifty Indices

Change in index

On 23 August, the NSE Index committee made some significant changes to the criteria and the composition of the various capitalization indices and sectoral indices. There are two very significant shifts that the Index Committee has made in the index criteria, effective 30-Sep.

The first big shift is with respect to the eligibility for inclusion of REITs and INVITs in the indices. Currently, only equity shares are eligible to be included in the index. Going ahead, even REITs and INVITs have been declared as eligible securities to be included in indices. This will bring a lot of global passive funds to invest in REITs and INVITs.

The second big change is to give a better representation to the pharma sector in the sectoral index. Currently, only the top-10 pharma stocks are considered for inclusion in the pharma index based on 6-month average free-float capitalization. That is now being modified to 20 pharma stocks to give a wider choice for inclusion in the pharma index.

Major changes in key indices

There will be no changes in the Nifty 50 Index composition as part of this semi-annual review. However, other indices are likely to see shifts as captured in the table.

NSE Index

Number of
stocks changed

Nifty Next  50


Nifty 500


Nifty 100


Nifty Midcap 150


Nifty Small Cap 250


Nifty Midcap 50


Nifty Midcap 100


Nifty Small Cap 50


Nifty Small Cap 100


Nifty 200


Nifty Large-Midcap 250


Nifty Mid-Small-cap 400


Nifty Microcap 250


Nifty FMCG


Nifty Healthcare


Nifty IT


Nifty Media



For a detailed list you can visit the NSE website at the following:

All the above changes will be effective from September 30th, 2021.

Next Article

Government plans to allow FDI in LIC


Foreign direct investment or FDI in the proposed LIC IPO may be permitted as a special case. To begin with, Indian government permits FDI in insurance up to 74% under the automatic route. Only if the FDI is above 74%, the matter is referred to the Cabinet Committee of Economic Affairs or CCEA for final approval. Then why does LIC need special approval?

The anomaly has to do with the regulatory ambit of LIC. Unlike other insurers that are entirely regulated by the Insurance Regulatory & Development Authority of India (IRDAI), LIC is governed by a statute of parliament under a separate Life Insurance Corporation Act. Hence the regular approval of 74% FDI will not apply to LIC and special approval has to be sought under the LIC Act, or an appropriate amendment made to the same.

The LIC IPO is expected to happen during the current fiscal year 2021-22 and the actuarial valuation report is still awaited. As per informal estimates, the government may sell around 5% stake in LIC as against the originally indicated 10%. The IPO will be a combination of a fresh issue and a sale of stake by the government of India. The indicative valuations of LIC based on its AUM and policyholder equity is pegged at over $250 billion, making it India’s most valuable company.

The government is clear that an IPO with a size of Rs.1 trillion cannot be absorbed by retail and HNIs, so aggressive institutional participation is inevitable. The government may also look at 75% allocation to QIBs to make absorption of the issue much easier. The government is firing on all cylinders as it needs to make a grand success of the LIC IPO if it has to even get close to its disinvestment target of Rs.175,000 crore for fiscal year 2021-22.


                         - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Read all stories on life insurance corporation (LIC) IPO:

1.   LIC - IPO Update
2.   LIC IPO gets the Government Stamp of Approval
3.   LIC IPO once step closer to becoming reality

Next Article

Bajaj Finserv gets Approval for Mutual Fund

Bajaj finance

Bajaj Finserv, the holding company of the consumer finance and insurance business of Bajaj group, got SEBI approval to sponsor a mutual fund AMC. The next steps for Bajaj Finserv would be to put in place a full-fledged asset management company as well as a trustee company to hold funds in trust.

The stock markets received the news with enthusiasm considering that the stock price scaled new highs in the aftermath of the news. If you look at the last 3 months, Bajaj Finserv is up nearly 42%, when the Nifty is up just 10%. That has been largely driven by the anticipated mutual fund approval for Bajaj Finserv.

The mutual fund segment in India currently manages over Rs.35 trillion with SBI Mutual Fund, ICICI Prudential Fund and HDFC Mutual Fund being top-3 in terms of AUM. There are over 40 AMCs in India but the top-10 AMCs account for over 80% of industry AUM. In short, this is a business where scale is a distinct advantage.

What is the distinct advantage for Bajaj Finserv from the AMC business. The first is synergy. Bajaj Finserv has built a solid retail franchise with deep reach across India through its consumer finance and insurance business. The AMC licence will facilitate Bajaj Finserv to cross sell one more product offering to its massive customer base.

The second advantage is valuations. Currently, there are 3 listed AMCs. While HDFC AMC is valued at 15% of AUM, Nippon AMC is at 10% and UTI AMC at 8% of AUM. Even if you assume a median valuation for Bajaj Finserv AMC business at around 12% of AUM, there is a lot of value that the group can build by originating mutual funds. For Bajaj Finserv, the AMC business will be a cross selling as well as value enhancement strategy.

Next Article

Rakesh Jhunjhunwala picks up 1.6% Stake in Canara Bank


Last week, we had reported about the Rs.2,500 crore qualified institutional placement (QIP) of equity shares by Canara Bank. This week it emerges that nearly Rs.431 crore in the QIP was invested by Rakesh Jhunjhunwala. In short, Jhunjhunwala has absorbed more than 17% of the total QIP issue of Canara Bank. Post the allotment, Rakesh Jhunjhunwala now holds a 1.59% stake in Canara Bank.

Canara did QIP of 16.74 crore shares to qualified institutional buyers at a price of Rs.149.35 per share taking the total size of the QIP to Rs.2,500 crore. Out of this total QIP placement, Canara Bank has allotted 2.885 crore shares to Rakesh Jhunjhunwala at the price of Rs.149.35 pegging his investment in the QIP at Rs.431 crore. However, there were other major QIPs that also participated in the QIP.

Check: Big Bull Rakesh Jhunjhunwala's Portfolio

While Rakesh Jhunjhunwala took 17% of the QIP issue, there were several institutions that took more than 5% of the QIP issue. The major investors in the QIP of Canara Bank included LIC (15.91%), BNP Paribas Arbitrage (12.55%), Societe Generale (7.97%), Indian Bank (6.37%), ICICI Prudential Life (6.37%), Morgan Stanley Asia (6.16%) and Volrado Venture Partners (6.05%).

However, on 25th August, after the disclosure, the stock of Canara Bank closed 3% lower at Rs.151.05 on the BSE. There could be two reasons for the tepid stock price performance. Firstly, the QIP placement has increased the paid up capital from Rs.1,647 crore to Rs.1,814 crore. To that extent, it will be EPS dilutive.

The other reason is that the market wants to see more traction in earnings growth and NIM expansion. The profit growth in the Jun-21 quarter was largely on the back of lower provisioning. Till there is greater clarity on performance, it looks like the markets will bide its time before getting enthusiastic about the stock.